General Counsel and Corporate Secretary · Clover Health Investments, Corp. (CLOV)

Karen Soares

FY2023 is the first fiscal year CompBrief holds for Karen Soares as a named executive officer of Clover Health Investments; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,466,496

Salary $402,404Stock awards $953,300

3rd of 5 named executive officers at Clover Health Investments by FY2023 total.

5 named officers on file for Clover Health Investments, FY2023

Karen Soares’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • CLOV’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Clover Health Investments’s whole pay program stands against its peers

  • Clover Health Investments’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLOV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Karen Soares’s full pay file as a PDF — free

More than this page: up to 10 years of Karen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Karen Soares compensation by year

Clover Health Investments Summary Compensation Table · the one fiscal year held
In US dollars, as Clover Health Investments reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$402,404
Bonus$0
Stock awards$953,300
Option awards$0
Non-equity incentive$101,706
Pension and deferred compensation$0
All other$9,087
Total$1,466,496

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Clover Health Investments, Corp. DEF 14A filed April 26, 2024, accession 0001801170-24-000094, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Clover Health Investments, Corp. filed document, accession 0001801170-24-000094. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU600,000$570,000—
PSU400,000$380,000—
RSU138,706$131,771—
RSU132,188$125,579—
RSU18,848$17,906—
Option40,432—$2.36
Option42,290—$2.36

Per the Outstanding Equity Awards at Fiscal Year-End table in Clover Health Investments, Corp.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

39 Form 4 lines since the FY2023 proxy (filed April 26, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-20Sale10b5-119,275$4.661,573,423
2026-10-15Sale10b5-114,673$4.681,592,698
2026-09-15Sale10b5-16,846$4.781,607,371
2026-08-12Grant or award—108,695$0.001,614,217
2026-07-20Sale10b5-151,700$4.511,505,522
2026-07-15Sale10b5-110,519$4.671,557,222
2026-06-15Sale10b5-14,681$4.611,567,741
2026-04-15Tax withholding—10,161$2.041,572,422

The 8 most recent of 39 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Clover Health Investments’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Andrew ToyCo-Founder and Chief Executive Officer$10,154,701
Jamie ReynosoChief Executive Officer of Medicare Advantage$2,494,844
Karen Soares · this pageGeneral Counsel and Corporate Secretary$1,466,496
Scott LefflerChief Financial Officer$1,402,851
Brady PriestChief Executive Officer of Home Care$1,346,996

The full Clover Health Investments compensation record

free company brief

This page is one person within Clover Health Investments's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Clover Health Investments proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Clover Health Investments's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Karen Soares's compensation dossier · One-time report. No refunds.